See more : Monterey Capital Acquisition Corporation (MCACW) Income Statement Analysis – Financial Results
Complete financial analysis of NorthWest Healthcare Properties Real Estate Investment Trust (NWHUF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NorthWest Healthcare Properties Real Estate Investment Trust, a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
- NEOJAPAN Inc. (NEOJF) Income Statement Analysis – Financial Results
- Tong Kee (Holding) Limited (8305.HK) Income Statement Analysis – Financial Results
- INDO AMERICAN SEAFOODS TBK (ISEA.JK) Income Statement Analysis – Financial Results
- Fireweed Metals Corp. (FWEDF) Income Statement Analysis – Financial Results
- Cascades Inc. (CADNF) Income Statement Analysis – Financial Results
NorthWest Healthcare Properties Real Estate Investment Trust (NWHUF)
About NorthWest Healthcare Properties Real Estate Investment Trust
NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at September 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 190 income-producing properties and 15.4 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand. The REIT's portfolio of medical office buildings, clinics, and hospitals is characterized by long term indexed leases and stable occupancies. With a fully integrated and aligned senior management team, the REIT leverages over 200 professionals across nine offices in 5 countries to serve as a long-term real estate partner to leading healthcare operators.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 522.68M | 448.83M | 374.61M | 373.82M | 366.06M | 349.59M | 313.97M | 277.35M | 198.96M | 150.43M | 150.11M | 134.46M | 118.15M | 64.97M |
Cost of Revenue | 121.37M | 100.48M | 68.55M | 76.36M | 75.92M | 79.59M | 74.18M | 72.65M | 53.00M | 69.64M | 68.59M | 60.83M | 53.68M | 18.77M |
Gross Profit | 401.30M | 348.35M | 306.07M | 297.46M | 290.13M | 270.00M | 239.78M | 204.70M | 145.96M | 80.79M | 81.52M | 73.63M | 64.48M | 46.20M |
Gross Profit Ratio | 76.78% | 77.61% | 81.70% | 79.57% | 79.26% | 77.23% | 76.37% | 73.81% | 73.36% | 53.71% | 54.31% | 54.76% | 54.57% | 71.11% |
Research & Development | 0.00 | 3.43M | 9.44M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 57.57M | 47.87M | 40.20M | 29.44M | 34.08M | 27.11M | 25.13M | 19.77M | 25.12M | 7.83M | 7.28M | 1.69M | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.76K | 71.25K | 0.00 | 0.00 |
SG&A | 57.57M | 47.87M | 40.20M | 29.44M | 34.08M | 27.11M | 25.13M | 19.77M | 25.12M | 7.83M | 7.29M | 1.77M | 3.22M | 1.82M |
Other Expenses | 0.00 | -15.22M | -10.35M | 81.65M | -46.99M | 35.50M | -24.02M | -25.58M | 514.00K | 8.76M | 15.38M | -7.54M | 40.42M | 0.00 |
Operating Expenses | 46.75M | 36.08M | 39.29M | 29.44M | 34.08M | 27.11M | 25.13M | 19.77M | 25.12M | 8.76M | 15.38M | -7.54M | 3.22M | 31.36M |
Cost & Expenses | 168.13M | 136.55M | 107.84M | 105.80M | 110.00M | 106.70M | 99.31M | 92.42M | 78.12M | 69.64M | 68.59M | 60.83M | 56.90M | 50.13M |
Interest Income | 46.50M | 9.18M | 4.60M | 1.95M | 6.44M | 11.24M | 4.55M | 2.85M | 912.00K | 834.00K | 816.00K | 2.00M | 97.58K | 0.00 |
Interest Expense | 233.85M | 163.88M | 102.17M | 103.33M | 130.81M | 143.40M | 105.44M | 85.90M | 78.00M | 31.60M | 31.25M | 28.42M | 23.43M | 13.79M |
Depreciation & Amortization | 1.27M | 1.40M | 1.38M | 1.58M | 1.98M | 1.30M | 1.41M | 750.00K | 275.00K | 1.56M | 1.56M | -1.25M | 0.00 | 20.27M |
EBITDA | 355.82M | 353.69M | 377.56M | 393.93M | 146.64M | 283.29M | 215.49M | 144.07M | 116.94M | 77.71M | 24.57M | 58.42M | 61.25M | 35.63M |
EBITDA Ratio | 68.08% | 80.17% | 95.67% | 105.38% | 40.06% | 81.04% | 68.64% | 51.95% | 58.78% | 51.66% | 56.76% | 43.44% | 51.84% | 54.83% |
Operating Income | 354.55M | 358.42M | 357.01M | 392.35M | 144.65M | 281.99M | 214.08M | 143.32M | 116.67M | 77.71M | 85.20M | 58.42M | 61.25M | 15.36M |
Operating Income Ratio | 67.83% | 79.86% | 95.30% | 104.96% | 39.52% | 80.66% | 68.19% | 51.68% | 58.64% | 51.66% | 56.76% | 43.44% | 51.84% | 23.64% |
Total Other Income/Expenses | -853.58M | -153.02M | 364.20M | -147.91M | 16.83M | -41.43M | 99.76M | -1.41M | 147.06M | -49.55M | -45.00M | 18.86M | 40.42M | 0.00 |
Income Before Tax | -499.03M | 204.92M | 736.07M | 396.24M | 161.48M | 201.46M | 276.42M | 183.52M | 259.95M | -22.20M | 36.52M | 92.49M | 101.67M | 0.00 |
Income Before Tax Ratio | -95.47% | 45.66% | 196.49% | 106.00% | 44.11% | 57.63% | 88.04% | 66.17% | 130.65% | -14.75% | 24.33% | 68.79% | 86.05% | 0.00% |
Income Tax Expense | -18.29M | 79.30M | 124.23M | 14.82M | 88.23M | 72.72M | 51.18M | 54.38M | 42.52M | 11.54M | 12.19M | 180.79K | 23.33M | 14.31M |
Net Income | -347.69M | 125.63M | 611.84M | 314.36M | 73.25M | 65.72M | 67.39M | 56.96M | 116.85M | -22.20M | 36.52M | 92.49M | 78.34M | 1.05M |
Net Income Ratio | -66.52% | 27.99% | 163.33% | 84.09% | 20.01% | 18.80% | 21.46% | 20.54% | 58.73% | -14.75% | 24.33% | 68.79% | 66.31% | 1.62% |
EPS | -1.46 | 0.53 | 2.73 | 1.79 | 0.48 | 0.63 | 0.67 | 0.82 | 2.22 | -0.57 | 0.94 | 2.40 | 2.22 | 0.04 |
EPS Diluted | -1.46 | 0.52 | 2.73 | 1.79 | 0.48 | 0.63 | 0.67 | 0.82 | 2.22 | -0.57 | 0.94 | 2.40 | 2.22 | 0.04 |
Weighted Avg Shares Out | 243.29M | 237.32M | 224.13M | 175.98M | 153.63M | 103.57M | 101.04M | 69.44M | 52.69M | 39.12M | 38.78M | 38.50M | 35.23M | 28.16M |
Weighted Avg Shares Out (Dil) | 243.29M | 240.65M | 224.13M | 175.98M | 153.63M | 103.57M | 101.04M | 69.44M | 52.69M | 39.12M | 38.78M | 38.50M | 35.23M | 28.17M |
Northwest Healthcare Properties Real Estate Investment Trust Announces July 2024 Distribution
NorthWest Healthcare Properties: Deserves More Credit Than Given
NorthWest Healthcare: 2025 Refinancing Still Represents The Ultimate Challenge
NorthWest Healthcare Properties Real Estate Investment Trust (NWHUF) Q1 2024 Earnings Call Transcript
Northwest Healthcare: 3 Takeaways From Q4 Results
NorthWest Healthcare REIT: Debenture Yields Reach 14%
NorthWest Healthcare Properties Real Estate Investment Trust (NWHUF) Q3 2023 Earnings Call Transcript
NorthWest Healthcare: Buy High-Sell Low, Why The Remaining Distribution Could Go
NorthWest Healthcare: The Distribution Is Set For A Big Cut
Northwest Healthcare: Balancing Potential Long-Term Benefits With Short-Term Considerations For Investors
Source: https://incomestatements.info
Category: Stock Reports